Extendicare Inc
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occup… Read more
Extendicare Inc (EXETF) - Net Assets
Latest net assets as of December 2025: $373.07 Million USD
Based on the latest financial reports, Extendicare Inc (EXETF) has net assets worth $373.07 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.07 Billion) and total liabilities ($692.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $373.07 Million |
| % of Total Assets | 35.01% |
| Annual Growth Rate | -2.08% |
| 5-Year Change | 266.03% |
| 10-Year Change | 113.47% |
| Growth Volatility | 65.23 |
Extendicare Inc - Net Assets Trend (1998–2025)
This chart illustrates how Extendicare Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Extendicare Inc (1998–2025)
The table below shows the annual net assets of Extendicare Inc from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $373.07 Million | +200.01% |
| 2024-12-31 | $124.35 Million | +41.44% |
| 2023-12-31 | $87.92 Million | -12.69% |
| 2022-12-31 | $100.70 Million | -1.20% |
| 2021-12-31 | $101.92 Million | -20.49% |
| 2020-12-31 | $128.19 Million | +11.07% |
| 2019-12-31 | $115.41 Million | -8.40% |
| 2018-12-31 | $125.99 Million | -2.30% |
| 2017-12-31 | $128.96 Million | -26.21% |
| 2016-12-31 | $174.76 Million | +1.53% |
| 2015-12-31 | $172.13 Million | +6974.16% |
| 2014-12-31 | $-2.50 Million | -106.61% |
| 2013-12-31 | $37.87 Million | -30.72% |
| 2012-12-31 | $54.66 Million | +13.12% |
| 2011-12-31 | $48.32 Million | +158.57% |
| 2010-12-31 | $18.69 Million | +145.69% |
| 2009-12-31 | $-40.90 Million | -38.50% |
| 2008-12-31 | $-29.53 Million | -25.25% |
| 2007-12-31 | $-23.58 Million | +0.32% |
| 2006-12-31 | $-23.65 Million | -104.76% |
| 2005-12-31 | $497.31 Million | +8.82% |
| 2004-12-31 | $456.99 Million | +28.21% |
| 2003-12-31 | $356.43 Million | -0.44% |
| 2002-12-31 | $358.03 Million | +2.09% |
| 2001-12-31 | $350.70 Million | -8.20% |
| 2000-12-31 | $382.02 Million | -12.66% |
| 1999-12-31 | $437.38 Million | -33.59% |
| 1998-12-31 | $658.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Extendicare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29943178300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $662.31 Million | 177.53% |
| Other Comprehensive Income | $-6.09 Million | -1.63% |
| Other Components | $16.28 Million | 4.36% |
| Total Equity | $373.07 Million | 100.00% |
Extendicare Inc Competitors by Market Cap
The table below lists competitors of Extendicare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ATHENS INTERNATIONAL AIRPORT S.
AT:AIA
|
$861.54 Million |
|
Acuren Corporation
NYSE:TIC
|
$861.59 Million |
|
Realord Group Holdings Limited
F:CUV
|
$861.91 Million |
|
Sichuan Crun Co Ltd
SHE:002272
|
$862.71 Million |
|
Nanfang Pump Industry
SHE:300145
|
$861.14 Million |
|
Brookfield Wealth Solutions Ltd.
NYSE:BNT
|
$861.05 Million |
|
Yantai Changyu Pioneer Wine Co Ltd
SHE:000869
|
$860.99 Million |
|
Hunan Junxin Environmental Protection Co. Ltd.
SHE:301109
|
$860.76 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Extendicare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 124,352,000 to 373,065,728, a change of 248,713,728 (200.0%).
- Net income of 96,577,231 contributed positively to equity growth.
- Dividend payments of 41,665,016 reduced retained earnings.
- New share issuances of 191,524,000 increased equity.
- Other comprehensive income increased equity by 671,968.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $96.58 Million | +25.89% |
| Dividends Paid | $41.67 Million | -11.17% |
| Share Issuances | $191.52 Million | +51.34% |
| Other Comprehensive Income | $671.97K | +0.18% |
| Other Changes | $1.61 Million | +0.43% |
| Total Change | $- | 200.01% |
Book Value vs Market Value Analysis
This analysis compares Extendicare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.15x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.08x to 2.15x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $8.55 | $9.23 | x |
| 1999-12-31 | $5.84 | $9.23 | x |
| 2000-12-31 | $5.21 | $9.23 | x |
| 2001-12-31 | $5.01 | $9.23 | x |
| 2002-12-31 | $4.92 | $9.23 | x |
| 2003-12-31 | $5.05 | $9.23 | x |
| 2004-12-31 | $6.58 | $9.23 | x |
| 2005-12-31 | $7.13 | $9.23 | x |
| 2006-12-31 | $-0.34 | $9.23 | x |
| 2007-12-31 | $-0.34 | $9.23 | x |
| 2008-12-31 | $-0.36 | $9.23 | x |
| 2009-12-31 | $-0.47 | $9.23 | x |
| 2010-12-31 | $0.23 | $9.23 | x |
| 2011-12-31 | $0.57 | $9.23 | x |
| 2012-12-31 | $0.54 | $9.23 | x |
| 2013-12-31 | $0.37 | $9.23 | x |
| 2014-12-31 | $-0.03 | $9.23 | x |
| 2015-12-31 | $1.74 | $9.23 | x |
| 2016-12-31 | $1.75 | $9.23 | x |
| 2017-12-31 | $1.29 | $9.23 | x |
| 2018-12-31 | $1.28 | $9.23 | x |
| 2019-12-31 | $1.29 | $9.23 | x |
| 2020-12-31 | $1.43 | $9.23 | x |
| 2021-12-31 | $1.13 | $9.23 | x |
| 2022-12-31 | $1.13 | $9.23 | x |
| 2023-12-31 | $1.03 | $9.23 | x |
| 2024-12-31 | $1.31 | $9.23 | x |
| 2025-12-31 | $4.30 | $9.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Extendicare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 25.89%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.82%
- • Asset Turnover: 1.56x
- • Equity Multiplier: 2.86x
- Recent ROE (25.89%) is below the historical average (27.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 9.95% | 3.09% | 0.95x | 3.38x | $-353.30K |
| 1999 | -36.63% | -8.44% | 1.03x | 4.21x | $-203.30 Million |
| 2000 | -15.54% | -3.28% | 1.04x | 4.55x | $-97.42 Million |
| 2001 | -10.38% | -2.14% | 0.98x | 4.96x | $-71.48 Million |
| 2002 | 5.29% | 1.08% | 0.97x | 5.06x | $-16.87 Million |
| 2003 | 17.02% | 3.52% | 1.08x | 4.47x | $25.03 Million |
| 2004 | 27.20% | 7.12% | 1.22x | 3.12x | $78.59 Million |
| 2005 | 18.94% | 4.78% | 1.16x | 3.41x | $44.46 Million |
| 2006 | 0.00% | -2.05% | 1.33x | 0.00x | $-33.36 Million |
| 2007 | 0.00% | 3.90% | 1.25x | 0.00x | $72.74 Million |
| 2008 | 0.00% | 0.65% | 1.14x | 0.00x | $16.34 Million |
| 2009 | 0.00% | 3.59% | 1.30x | 0.00x | $81.80 Million |
| 2010 | 223.84% | 2.02% | 1.22x | 90.87x | $39.96 Million |
| 2011 | -62.91% | -1.45% | 1.14x | 37.89x | $-35.23 Million |
| 2012 | 114.63% | 3.08% | 1.13x | 33.08x | $57.19 Million |
| 2013 | 13.95% | 0.26% | 1.09x | 48.83x | $1.50 Million |
| 2014 | 0.00% | -2.30% | 0.43x | 0.00x | $-18.50 Million |
| 2015 | 134.83% | 23.69% | 0.95x | 5.97x | $214.87 Million |
| 2016 | 20.29% | 3.34% | 1.07x | 5.66x | $17.98 Million |
| 2017 | 1.65% | 0.19% | 1.17x | 7.24x | $-10.76 Million |
| 2018 | 25.19% | 2.83% | 1.25x | 7.11x | $19.14 Million |
| 2019 | 24.81% | 2.53% | 1.27x | 7.70x | $17.09 Million |
| 2020 | 42.27% | 4.68% | 1.20x | 7.51x | $41.37 Million |
| 2021 | 11.29% | 0.99% | 1.30x | 8.83x | $1.31 Million |
| 2022 | 69.07% | 5.69% | 1.56x | 7.76x | $59.48 Million |
| 2023 | 38.65% | 2.60% | 1.94x | 7.65x | $25.19 Million |
| 2024 | 60.48% | 5.13% | 2.04x | 5.79x | $62.77 Million |
| 2025 | 25.89% | 5.82% | 1.56x | 2.86x | $59.27 Million |
Industry Comparison
This section compares Extendicare Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Extendicare Inc (EXETF) | $373.07 Million | 9.95% | 1.86x | $861.34 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |